MAPT and Cognitive impairment: A selective p38α MAPK direct inhibitor 8 has been reported to suppress the activity of p38α MAPK and, therefore, decrease tau phosphorylation and restrain cognitive impairment in aged hTau mice (Watterson et al., 2013).